Pressure ulcer development in patients treated for acute ischaemic stroke

J Wound Care. 2024 Jun 2;33(6):441-449. doi: 10.12968/jowc.2020.0331.

Abstract

Objective: The aim of this study was to determine the incidence of pressure ulcers (PUs) in patients treated for acute ischaemic stroke (AIS) and to evaluate comorbid/confounding factors.

Method: The study included patients treated for AIS who were divided into three treatment groups: those receiving intravenous tissue plasminogen activator therapy (tPA); patients receiving mechanical thrombectomy (MT); and those receiving both tPA and MT. PUs were classified according to the international classification system and factors that may influence their development were investigated.

Results: A total of 242 patients were included in this study. The incidence of PUs in patients treated for AIS was 7.4%. Most PUs were located on the sacrum (3.7%), followed by the gluteus (3.3%) and trochanter (2.9%). With regards to PU classification: 29% were stage I; 34% were stage II; and the remainder were stage III. Age was not a significant factor in the development of PUs (p=0.172). Patients in the tPA group had a lower PU incidence (2.3%) than patients in the tPA+MT group (15.7%) and MT group (12.1%) (p=0.001). Patients with PUs had a longer period of hospitalisation (18.5±11.92 days) than patients without a PU (8.0±8.52 days) (p=0.000). National Institute of Health Stroke Scale (NIHSS) scores at admission were higher in patients with PUs than in patients without a PU (14.33±4.38 versus 11.08±5.68, respectively; p=0.010). The difference in presence of comorbidities between patients with and without PUs (p=0.922) and between treatment groups (p=0.677) were not statistically significant. The incidence of PUs was higher in patients requiring intensive care, but this difference was not statistically significant (p=0.089).

Conclusion: In this study, patients treated for AIS with high NIHSS scores at admission and/or receiving MT were at higher risk for PUs, and so particular attention should be given to these patients in order to prevent PU development.

Keywords: International Pressure Ulcer Classification System; National Institutes of Health Stroke Scale; acute ischaemic stroke; intravenous tissue plasminogen activator therapy; mechanical thrombectomy; pressure ulcer; stroke; ulcer; wound; wound care; wound dressing; wound healing.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Incidence
  • Ischemic Stroke* / epidemiology
  • Ischemic Stroke* / therapy
  • Male
  • Middle Aged
  • Pressure Ulcer* / epidemiology
  • Pressure Ulcer* / therapy
  • Retrospective Studies
  • Risk Factors
  • Thrombectomy
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Tissue Plasminogen Activator
  • Fibrinolytic Agents